Ncardia: Funding, Investors & Team (Sep 2026)
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.
Ncardia has raised $60.0M across 1 funding round on record, the most recent an undisclosed round of $60.0M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ncardia Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Ncardia Funding Rounds
Ncardia Founders and Leadership Team
No contact details are on record for this team yet.
Ncardia Funding Compared to Other Biotechnology Startups
Ncardia's latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ncardia in Biotechnology and Leiden
Companies Similar to Ncardia
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Ncardia Funding FAQs
What does Ncardia do?
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.
How much funding has Ncardia raised?
Ncardia has raised $60.0M across 1 round on record. The most recent is an undisclosed round of $60.0M announced in Nov 2021.
When did Ncardia last raise funding?
Ncardia's most recent funding round on record is an undisclosed round of $60.0M, announced in Nov 2021.
Who is the CEO of Ncardia?
Stefan Braam is listed as CEO at Ncardia.
Where is Ncardia headquartered?
Ncardia is based in Leiden, Zuid-Holland, Netherlands.
How many employees does Ncardia have?
Ncardia is in the 11-50 employee band.
How does Ncardia's funding compare to other Biotechnology startups?
Ncardia's latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Ncardia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ncardia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.